However, this hypothesis has not been extensively studied in the context of atherosclerosis
Conclusion - GLP 1 demands new standards in precision, flexibility, and speed The industrial processing of GLP-1 products places high demands on facilities, processes, and quality assurance measures
The traditional endocrinology pathway was designed for complex metabolic disease management, not for the 70+ million Americans who meet clinical criteria for GLP-1 therapy but don't have comorbidities requiring specialist oversight
Functional variability across liver cell subtypes, immune cells, and metabolic tissues could produce bidirectional or even contradictory effects in different physiological contexts
Emotionally, I began to feel more like myself again, Whittnie says
On the other, we risk medicalising thinness, increasing drug dependency, or diverting access from those most in need